June 2, 2026

Servier to acquire Edgewise’s muscular dystrophy business for $2.65bn

​Servier has signed an agreement to acquire Edgewise Therapeutics’ muscular dystrophy business in a deal valued at up to $2.65bn.The...

June 1, 2026

SKIA secures FDA 510(k) clearance for AR surgical platform

​South Korean medical technology company SKIA has received FDA 510(k) clearance for its SKIA HEAD, its AR surgical guidance system.The...

June 1, 2026

FDA approves AstraZeneca’s Imfinzi-BCG combination for NMIBC therapy

​AstraZeneca has secured FDA approval for Imfinzi in combination with BCG induction and maintenance therapy for adults with BCG-naïve, high-risk...

June 1, 2026

Labcorp announces partnership for colorectal cancer trials

​Labcorp has collaborated with the Alliance for Clinical Trials in Oncology on a new study that seeks to expand access...

May 29, 2026

Kalohexis doses first patients in 710GO Phase I trial for obesity

​Kalohexis has dosed the first patients in its Phase I FIH clinical trial of 710GO, an oral dual MC3R/MC4R agonist...

May 29, 2026

Procept secures FDA IDE for Aquablation and completes WATER IV study enrolment

​Procept BioRobotics has received a second FDA IDE to allow another randomised study of its Aquablation therapy.The post Procept secures...

May 29, 2026

FDA grants priority review for Sanofi’s venglustat NDA

​Sanofi has received a priority review from the FDA for its NDA for venglustat, an oral GCSi intended for the...

May 27, 2026

ABILITY Neurotech receives MREC approval for ALS BCI clinical trial

​ABILITY Neurotech has secured approval from the MREC NedMec in the Netherlands to initiate a chronic clinical trial of its...

May 27, 2026

First participant dosed in Jade’s Phase II JUNIPER trial for IgAN

​Jade Biosciences has dosed the first participant in its Phase II JUNIPER clinical trial, evaluating JADE101 for IgAN.The post First...

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.